Tuesday, 21 July 2026

 

 

LATEST NEWS "Democracy functions through representation; elected representatives should raise people's issues in Parliament": Anil Vij Make Environmental Protection a People's Movement: CM Nayab Singh Saini Use Treated Water Scientifically and in a Planned Manner : Nayab Singh Saini Nation's Youth & Farmers Are on Roads, but Instead of Dialogue, BJP Govt Is Using Force to Silence Their Voices : Baltej Pannu PM Modi Recognised Me Instantly; His Affection for Party Workers is Unparalleled : Vineet Joshi NEET (UG)-2026 All India Rank-2 Panshul Bansal Calls on Chief Minister CM Condoles Demise of Former MLA Rajpal Bhukhri, Visits Bereaved Families in Narayangarh Every eligible individual must get their name registered in the voter list to strengthen democracy: Nayab Singh Saini Chief Electoral Officer Reviews Progress of Special Intensive Revision of Electoral Rolls Air India Selects New JFK Terminal 6 For Future Operations IIHMR University Convocation 2026 Celebrates India's Next Generation of Healthcare Leaders 46 KCP-PWG Militants Surrender in Major Manipur Breakthrough NABARD's ₹15,056-Crore Push Reshapes Rural Haryana CM Suvendu Adhikari launches app to report electricity theft Vipul Goel chairs 8th Board Meeting of Haryana Airports Development Corporation Government Focused on Equipping ITI Students with Modern Skills for Industry- Gaurav Gautam Dr Himanshu Aggarwal Conducts Surprise Inspection of Seva Kendra and Sub-Registrar Office Amarinder Singh Raja Warring condemns Mann for dancing to Shah’s tunes Ahead of Monsoon, Baliawal Seeks Urgent Repair of Sahnewal Embankments and Action Against Illegal Mining Dr. Jitendra Singh meets Rahul Gandhi as Cong leadership protests outside PM’s house J&K to Host Mega Job Fair with 10,000+ Vacancies

 

AstraZeneca, blood clots link 'plausible but not confirmed' : WHO

Coronavirus, COVID 19, Novel Coronavirus, Fight Against Corona, Corona Virus Updates ,Coronavirus Epidemic, Coronavirus Pandemic, Corona virus threat, Corona Outbreak, Covaxin, Covishield, Covid-19 Vaccine, COVID-19 Vaccination, COVID Vaccination, Coronavirus Vaccine, AstraZeneca, AstraZeneca Covid-19 vaccine, Global Advisory Committee on Vaccine Safety, GACVS, World Health Organization, Geneva, European Medicines Agency, EMA

Web Admin

Web Admin

5 Dariya News

Geneva , 08 Apr 2021

Last updated on: Apr 08, 2021, 00:00 IST

A causal link between the AstraZeneca Covid-19 vaccine and the rare occurrence of blood clots with low platelets is "considered plausible but not confirmed," the World Health Organization (WHO) said.Earlier on the day, the European Medicines Agency (EMA) confirmed that the cases of blood clots with low blood platelets were associated with the administration of the AstraZeneca Covid-19 vaccine, but should still be listed as very rare side effects.In an interim statement on Wednesday, the WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that the events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca vaccine around the world, Xinhua news agency reported.However, specialized studies are needed to fully understand the potential link, and the GACVS said it will continue to gather and review further data.Meanwhile, the GACVS added that rare adverse events following immunizations should be assessed against the risk of deaths from Covid-19 and the potential of the vaccines to prevent infections and reduce deaths. According to the WHO's statistics, as of Wednesday, at least 2.6 million people have died of Covid-19 worldwide.

Several European countries have already halted or suspended the rollout of the AstraZeneca vaccine in view of the reported risks. On Wednesday, the WHO said that the side effects, mostly mild and local in nature, are "expected" and "common" within two or three days following vaccination.It also recommended that individuals who experience any severe symptoms, such as shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms such as severe and persistent headaches or blurred vision, tiny blood spots under the skin beyond the site of the injection, from around four to 20 days following vaccination should seek urgent medical attention."In extensive vaccination campaigns, it is normal for countries to identify potential adverse events following immunization," the GACVS said. "This does not necessarily mean that the events are linked to the vaccination itself, but they must be investigated to ensure that any safety concerns are addressed quickly."Vaccines, like all medicines, can have side effects. The administration of vaccines is based on a risk versus benefit analysis," it added.

 

Tags: Coronavirus , COVID 19 , Novel Coronavirus , Fight Against Corona , Corona Virus Updates , Coronavirus Epidemic , Coronavirus Pandemic , Corona virus threat , Corona Outbreak , Covaxin , Covishield , Covid-19 Vaccine , COVID-19 Vaccination , COVID Vaccination , Coronavirus Vaccine , AstraZeneca , AstraZeneca Covid-19 vaccine , Global Advisory Committee on Vaccine Safety , GACVS , World Health Organization , Geneva , European Medicines Agency , EMA

 

 

related news

 

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2026 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD